Appleyard Lees is a leading intellectual property law firm with over 45 patent and trade mark attorneys and specialist solicitors. The firm supports some of the world’s most innovative businesses and leading academic institutions, helping them to maximise the value of their intellectual property throughout its entire life cycle. With a network of UK offices in Cambridge, Leeds, Halifax, Manchester and the Alderley BioHub, the firm has an unrivalled reputation for quality and professionalism, providing clients with expert strategic IP advice globally.
Bureau Van Dijk
Orbis Intellectual Property links global patent data to companies and corporate groups in a way that’s never been done before.
With information on around 300 million companies worldwide, we are the resource for private company data. We’ve linked 115 million patents to that company information to give you extensive patent portfolios for a company and its corporate group. It’s a comprehensive solution for intellectual property management and research strategy, saving you time and helping you make faster, better decisions.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises.
Welcome Reception Sponsors
Leading international patent and trade mark firm, Haseltine Lake, and boutique IP law firm, Kempner & Partners, have joined forces to create a new IP powerhouse, and a new choice for clients. The combined firm, Haseltine Lake Kempner, will provide a full suite of IP services advising across the entire IPR Lifespan™ and in all technical and scientific disciplines. With offices in London, Munich, Bristol, Leeds, Glasgow, The Netherlands and Guangzhou (China), Haseltine Lake Kempner has built a strong international reputation for top quality advice across the globe. The firm has been helping universities and their technology transfer arms with their Intellectual Property (IP) challenges for decades, securing their innovations across a range of technologies. Haseltine Lake Kempner is proud to continue its support of the largest event in the KEC sector, the annual PraxisAuril conference.
IN-PART is an online matchmaking platform for university-industry collaboration that provides the initial introduction for new partnerships. Our aim is to unlock innovation from research by simplifying the process through which teams in academia and industry start conversations to get ideas out of the lab and onto the market.
Intellectual Property Office
The Intellectual Property Office (IPO) is the official government body responsible for registration, policy and support for intellectual property (IP). We operate and maintain a clear and accessible IP system in the UK, which encourages innovation and helps the economy and society to benefit from knowledge and ideas. The IPO hosts a number of resources to support university-business collaborations and help maximise the impact of research, including the Lambert toolkit model agreements and the IP for Research resources.
IP Pragmatics is a management consultancy specialising in scientific technologies and intellectual property (IP). The company is headquartered in London with offices in Scotland and Australia. We also have strategic partners in Japan and North America. Our IP value creation services include: IP auditing and valuation; market research and analysis; business development and licensing, and patent landscaping analysis. We also provide a high value patent and trade mark annuity payment services through our strategic partner IPRIS. We work broadly across many technology sectors and have particular expertise in the following areas: IP Analytics, Human Health, Animal Health, Agritech, Food & Nutrition, Life Science Research and Cleantech.
LifeArc is a medical research charity with a 25-year legacy of helping scientists and organisations turn their research into treatments and diagnostics for patients. LifeArc turns innovative science into patient impact. The charity brings together a network of partners to tackle specific diseases and directly funds academic and early stage research. So far, LifeArc’s work has helped to develop four drugs (Keytruda®, Actemra®, Tysabri® and Entyvio®) and a test for resistance to carbapenems.
www.lifearc.org Twitter: @lifearc1
Winner of the prestigious Queen’s Award for International Trade again in 2015, Minesoft has fast become an established leader in the field of Patent Information, working with academic institutions, industrial corporations, patent attorney firms and patent authorities around the world. Minesoft’s flagship product PatBase enables users to protect their designs by checking novelty against existing patents and to solve technical dilemmas by studying patent texts, patent drawings and non-patent literature. Speed up your research with patent data from over 100 countries to find partnerships, investment and commercialisation opportunities. Access and understand the most up-to-date scientific research, new ideas and competitor information contained in patent documents. Discover the most comprehensive global patent citation database available, Citation Explorer, ideal for unearthing new players or technologies and identifying potential licensees – fully included in all PatBase subscriptions. Effortlessly visualize the landscape with newly launched PatBase Analytics V2: gain actionable competitive intelligence, pinpoint licensing opportunities and discover the white spaces in areas of interest. Visit the Minesoft stand for more information and a demonstration!
RWS is the world leader in translation and localization and, intellectual property support solutions. For more than 60 years, we have led the industry and helped more than 10,000 clients protect their IP and enforce their rights around the world. With staff of over 2400 and offices in Europe, North and South America and APAC, RWS serves clients worldwide. Learn more at www.rws.com.
UK Research and Innovation is a new body which works in partnership with universities, research organisations, businesses, charities, and government to create the best possible environment for research and innovation to flourish. We aim to maximise the contribution of each of our component parts, working individually and collectively. We work with our many partners to benefit everyone through knowledge, talent and ideas.
Operating across the whole of the UK with a combined budget of more than £7 billion, UK Research and Innovation brings together the Arts and Humanities Research Council; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Innovate UK; Medical Research Council; Natural Environment Research Council; Research England; and Science and Technology Facilities Council.
Viadynamics is an innovation and venturing agency. For the last 20 years we have specialised in solving innovation dilemmas for big business, SME’s, start-ups, universities and the third sector. We have worked with over 20 universities in the UK and Europe who are seeking to maximise their knowledge exchange capabilities and impact. We have worked on everything from Knowledge Exchange Strategies to Enterprise Fellowship Programmes and multi-disciplinary, cross sector ecosystems – as well as student and staff entrepreneurship training.
We bring knowledge and experience of the barriers and enablers to innovation and entrepreneurship from each of these sectors to bear on the challenges we address with University partners.
Ximbio is the world’s largest non-profit dedicated to life science research reagents of all kinds including antibodies, cell lines, mouse models and small molecules. Scientists can exchange knowledge and maximise commercial opportunities for research reagents they have created. Our mission is to make these novel reagents easily available to scientists to accelerate life science research.
These reagents are the cornerstones of basic scientific research that scientists can use to test their hypotheses, validate their ideas or develop new concepts. Ximbio provides a service for inventors, suppliers and users of novel reagents which contributes to our primary mission of advancing scientific research.